for the Company’s groundbreaking 12-lead electrocardiogram (ECG) synthesis software designed for the assessment of rhythms and arrhythmias, including sinus rhythm, atrial fibrillation ...
HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...
vip.sina.com Objective To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China. Methods We conducted a community-based survey of 47 841 adults (age ≥45 years) ...